Type 2 Diabetes

Researchers compared four different methods of estimating starting basal insulin infusion rates when transitioning to pump therapy. Which was best?

There are many ways patients can better manage their cholesterol than they could just a few years ago. Whether they are successful in those efforts and the role of doctors and medications in that process remains to be seen.

Only a handful of medications carry an FDA indication for obesity, but metformin (which currently does not) has weighty evidence supporting its use.

Researchers report that St. John’s Wort produces persistent glucose intolerance via decreased beta-cell function. St. John’s Wort may increase risk of type 2 diabetes in the already at-risk depressed population.

Recent findings show a link between obstructive sleep apnea (OSA) & type 2 diabetes. A new study examines cortisol levels & glucose metabolism in OSA.

Are diabetic patients at an increased risk of infection with community-acquired Staphylococcus aureus? If so, can risks be mitigated?

Why would the pancreas need a bacteria-killing protein when it isn’t normally exposed to bacteria? A Canadian team has the answer.

Whether used as monotherapy or dual therapy, is there an advantage to using one specific SGLT2 inhibitor over another?

How much of an effect does sedentary behavior have on glucose metabolism status and metabolic syndrome?

Despite a considerable gap between the number of patients who require a transplant and the number of organs available those patients fortunate enough to receive the lifesaving organs are seeing greater success from the procedure.

There is no shortage of people in need of a kidney transplant but a considerable shortage in the number of organs available to these patients. Despite that health care professionals in nephrology are determined to provide their patients the highest quality of life possible in spite of these challenges.

Studies of cancer risks with diabetes have been comprised mostly of people with T2DM, leaving the links between cancer and T1DM relatively unknown.

Many factors and competing responsibilities dictate how many patients you can see in one day. What’s your ideal number?

Unlike typical Western patients, type 2 diabetes patients in Asia tend to have lower BMIs. Does this mean responses to GLP-1 RAs differ as well?

When diabetes first became a concern in the medical community the numbers were lower, but the consequences were much more severe. Today, many more people are diagnosed with types one and two diabetes but the treatment options are much safer and more effective.

Latent autoimmune diabetes can be a tough diagnosis to make. Our blogger shares some pointers on this little-understood subtype of diabetes.

DCAN remains overlooked as an important risk factor for cardiac morbidity and mortality in diabetes.

SGLT2 inhibitors are known to lower blood pressure, but how best to use these drugs with blood pressure lowering medications remains an open question.

The Endocrine Society released a new clinical practice guideline covering diagnosis and treatment of primary adrenal insufficiency in January 2016. The European Society of Endocrinology and the American Association for Clinical Chemistry co-sponsored this document.

Older patients with type 2 diabetes are a highly variable population with different requirements for diabetes management.

The past 30 years have witnessed major advances in PCI; fewer changes have occurred with CABG, though the death rate has decreased. Which is better?

What will the burden on the health system be if non-compliant patients are dismissed from practices and deprived of care?

The hormonal changes of adolescence can wreak havoc on glucose control, but what else can affect disease management in teens?